Literature DB >> 15462637

General practitioners' response to depression and anxiety in the Australian community: a preliminary analysis.

Ian B Hickie1, Jane E Pirkis, Grant A Blashki, Grace L Groom, Tracey A Davenport.   

Abstract

OBJECTIVES: To examine the uptake by general practitioners (GPs) of the five key components of the Better Outcomes in Mental Health Care (BOiMHC) initiative: education and training for GPs; the three-step mental health process; focussed psychological strategies; access to allied health services; and access to psychiatrist support.
SETTING: All Australian states and territories during the first 15 months of the initiative (1 July 2002 - 30 September 2003).
DESIGN: Retrospective survey of de-identified registration data held by the General Practice Mental Health Standards Collaboration (training uptake), de-identified Health Insurance Commission (HIC) billing data (provision of the three-step mental health process, focussed psychological strategies and case conferences with psychiatrists), and reports from "access to allied health services" projects to the Australian Department of Health and Ageing (project participation). MAIN OUTCOME MEASURES: Number and percentage of Australian GPs certified as eligible to participate in the initiative; provision of the three-step mental health process and focussed psychological strategies by GPs; participation in allied health pilot projects; and access to psychiatrist support.
RESULTS: Within 15 months of the BOiMHC initiative commencing, 3046 GPs (about 15% of Australian GPs) had been certified as eligible to participate, including 387 who had registered to provide focussed psychological strategies. GPs had completed 11 377 three-step mental health processes and 6472 sessions of focussed psychological strategies. Sixty-nine "access to allied health services" projects had been funded, with the original 15 pilot projects enabling 346 GPs to refer 1910 consumers to 134 individual allied health professionals and 10 agencies. In contrast, the "access to psychiatrist support" component was less successful, with the HIC billed for 62 case conferences at which a psychiatrist and a GP were present.
CONCLUSION: The level of uptake of the main components of the BOiMHC initiative has expanded the national capacity to respond to the needs of people with common mental disorders, such as depression and anxiety.

Entities:  

Mesh:

Year:  2004        PMID: 15462637

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Does Introducing Public Funding for Allied Health Psychotherapy Lead to Reductions in Private Insurance Claims? Lessons for Canada from the Australian Experience.

Authors:  Sandra Diminic; Mary Bartram
Journal:  Can J Psychiatry       Date:  2018-06-20       Impact factor: 4.356

2.  Managing depression in a changing primary mental healthcare system: comparison of two snapshots of Australian GPs' treatment and referral patterns.

Authors:  Heather McGarry; Kelsey Hegarty; Caroline Johnson; Jane Gunn; Grant Blashki
Journal:  Ment Health Fam Med       Date:  2009-06

3.  Trends in sickness certification of injured workers by general practitioners in Victoria, Australia.

Authors:  Rasa Ruseckaite; Alex Collie; Megan Bohensky; Bianca Brijnath; Agnieszka Kosny; Danielle Mazza
Journal:  J Occup Rehabil       Date:  2014-09

4.  Recognition and treatment of depression: a comparison of Australian and Chinese medical students.

Authors:  Ye Rong; Georgina M Luscombe; Tracey A Davenport; Yueqin Huang; Nick Glozier; Ian B Hickie
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-20       Impact factor: 4.328

5.  Achievements of the Australian Access to Allied Psychological Services (ATAPS) program: summarising (almost) a decade of key evaluation data.

Authors:  Bridget Bassilios; Angela Nicholas; Lennart Reifels; Kylie King; Justine Fletcher; Anna Machlin; Maria Ftanou; Grant Blashki; Philip Burgess; Jane Pirkis
Journal:  Int J Ment Health Syst       Date:  2016-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.